Mylan
Yupelri
Manufacturer:
Mylan
Name:
Yupelri
HCPCS Code Descriptor:
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
Category:
J Code
HCPCS:
J7677
NDC(s):
49502-0806-93
Primary Type:
Respiratory
Generic/Specialty Status:
Single-Source
Route of Administration:
Inhalation
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
Yupelri is a Respiratory drug manufactured by Mylan and administered via the Inhalation route of administration. The J Code: J7677 is aligned to the drug Yupelri.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/19
HCPCS Effective Date:
7/1/19
HCPCS Short Description:
Revefenacin inh non-com 1mcg
Billing and Coding Guide:
https://www.yupelrihcp.com/-/media/Project/Common/YupelriHCP/pdf/REV_2020_0151_Billing_Reimbursement-Guide.pdf
Patient Assistance:
https://www.viatris.com/en-us/lm/united-states/patient-assistance-program